Elanco Animal Health Incorporated Restricted Cash, Current
Elanco Animal Health Incorporated (ELAN) had Restricted Cash, Current of $0 as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:RestrictedCashCurrent · last filed 2022-02-28
- 2021-12-31: Restricted Cash, Current $0.00.
- 2021-09-30: Restricted Cash, Current $0.00.
- 2021-06-30: Restricted Cash, Current $0.00.
- 2021-03-31: Restricted Cash, Current $0.00.
| Period end | Restricted Cash, Current | Restricted Cash, Current as first filed |
|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $11.00M 10-K · filed 2022-02-28 | $10.70M 10-K · filed 2021-03-01 |
| 2020-09-30 | $11.00M 10-Q · filed 2021-11-05 | $10.70M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $11.00M 10-Q · filed 2021-08-09 | $10.70M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $11.00M 10-Q · filed 2021-05-07 | $10.70M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $11.00M 10-K · filed 2022-02-28 | $11.10M 10-K · filed 2020-02-28 |
| 2019-09-30 | $11.10M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $11.50M 10-Q · filed 2020-07-30 | |
| 2019-03-31 | $28.50M 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $202.70M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $634.90M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-13 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $0.00 10-K · filed 2020-02-28 | |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |